Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndrome

Clinical Immunology

Volumn 156, Issue 1, 2015, Pages 36-42

  Chida, Natsuko ^a,b   Kobayashi, Ichiro ^a   Takezaki, Shunichiro ^a   Ueki, Masahiro ^a   Yamazaki, Yasuhiro ^a   Garelli, Silvia ^c   Scarpa, Riccardo ^c   Horikawa, Reiko ^d   Yamada, Masafumi ^a   Betterle, Corrado ^c   Notarangelo, Luigi D ^e   Yawaka, Yasutaka ^b   Ariga, Tadashi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF PADOVA   (Italy)

^d NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

AIE 75; APECED; IPEX syndrome; Tryptophan hydroxylase; Villin

Indexed keywords

AUTOANTIBODY; AUTOIMMUNE ENTEROPATHY RELATED 75 ANTIGEN; TRYPTOPHAN HYDROXYLASE; UNCLASSIFIED DRUG; VILLIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TPH1 PROTEIN, HUMAN; USH1C PROTEIN, HUMAN;

ADULT; ALOPECIA; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE HEPATITIS; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE THYROIDITIS; CLINICAL ARTICLE; DIARRHEA; DISEASE MARKER; DISEASE SEVERITY; ECZEMA; ETHNICITY; FEMALE; FOOD ALLERGY; HUMAN; IMMUNOLOGICAL TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; IPEX SYNDROME; MALE; NEPHROTIC SYNDROME; PSORIASIS; BLOOD; DIFFERENTIAL DIAGNOSIS; GENETIC DISEASES, X-LINKED; IMMUNOBLOTTING; IMMUNOLOGY; METABOLISM; POLYENDOCRINOPATHIES, AUTOIMMUNE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUTOANTIBODIES; DIAGNOSIS, DIFFERENTIAL; GENETIC DISEASES, X-LINKED; IMMUNE TOLERANCE; IMMUNOBLOTTING; POLYENDOCRINOPATHIES, AUTOIMMUNE; TRYPTOPHAN HYDROXYLASE;

EID: 84911892188     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.10.010     Document Type: Article

References (36)

1. Mathi D., Benoist C. Aire. Annu. Rev. Immunol. 2009, 27:287-312.
2. Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Ann. Rev. Immunol. 2004, 22:531-562.
3. Campbel D.J., Koch M.A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 2011, 11:119-130.
4. Barzaghi F., Passerini L., Bacchetta R. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front. Immunol. 2012 Jul 31, 3:211. 10.3389/fimmu.2012.00211. eCollection 2012.
5. Montalto M., D'Onofrio F., Santoro L., Gallo A., Gasbarrini A., Gasbarrini G. Autoimmune enteropathy in children and adults. Scand. J. Gastroenterol. 2009, 44(9):1029-1036.
6. Kobayashi K., Imamura M., Yamada M., Okano A., Yara S., Ikema N., et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin. Exp. Immunol. 1998, 111:527-531.
7. Kobayashi I., Imamura K., Kubota M., Ishikawa S., Yamada M., Tonoki H., et al. Identification of an autoimmune enteropathy-related 75-kilodalton antigen. Gastroenterology 1999, 117:823-830.
8. Kobayashi I., Kubota M., Yamada M., Tanaka H., Itoh S., Sasahara Y., et al. Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3. Clin. Immunol. 2011, 141:83-89.
9. Moes N., Rieux-Laucat F., Begue B., Verdier J., Neven B., Patey N., et al. Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology 2010, 139:770-778.
10. Lampasona V., Passerini L., Barzaghi F., Lombardoni C., Bazzigaluppi E., Brigatti C., et al. Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome. PLoS ONE 2013 Nov 8, 8(11):e78664. 10.1371/journal.pone.0078664. eCollection 2013.
11. Ekwall O., Hedstrand H., Grimelius L., Haavik J., Perheentupa J., Gustafsson J., et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet 1998, 352:279-283.
12. Ekwall O., Sjöberg K., Mirakian R., Rorsman F., Kämpe O. Tryptophan hydroxylase autoantibodies and intestinal disease in autoimmune polyendocrine syndrome type 1. Lancet 1999, 354:568.
13. Dal Pra C., Chen S., Betterle C., Zanchetta R., McGrath V., Furmaniak J., et al. Autoantibodies to human tryptophan hydroxylase and aromatic l-amino acid decarboxylase. Eur. J. Endocrinol. 2004, 150:313-321.
14. Scarpa R., Alaggio R., Norberto L., Furmaniak J., Chen S., Smith B.R., et al. Tryptophan hydroxylase autoantibodies as markers of a distinct autoimmune gastrointestinal component of autoimmune polyendocrine syndrome type 1. J. Clin. Endocrinol. Metab. 2013, 98:704-712.
15. Sayar E., Islek A., Yilmaz A., Elpek G.O., Artan R. Intestinal dysfunction in APECED syndrome could mimic IPEX syndrome. J. Pediatr. Gastroenterol. Nutr. 2013, 56:e27. 10.1097/MPG.0b013e318283f3c8.
16. Nieves D.S., Phipps R.P., Pollock S.J., Ochs H.D., Zhu Q., Scott G.A., et al. Dermatologic and immunologic findings in the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Arch. Dermatol. 2004, 140:466-472.
17. Sato U., Horikawa R., Katsumata N., Asakura Y., Kitanaka S., Tanaka T. Novel compound heterozygous mutations in a Japanese patient with APECED. J. Pediatr. Endocrinol. Metab. 2004, 17:917-921.
18. De Martino L., Capalbo D., Improda N., D'Elia F., Di Mase R., D'Assante R., et al. APECED: a paradigm of complex interactions between genetic background and susceptibility factors. Front. Immunol. 22 October 2013, 10.3389/fimmu.2013.00331.
19. Söderbergh A., Myhre A.G., Ekwall O., Gebre-Medhin G., Hedstrand H., Landgren E., et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J. Clin. Endocrinol. Metab. 2004, 89:557-562.
20. De Serre N.P., Canioni D., Ganousse S., Rieux-Laucat F., Goulet O., Ruemmele F., Brousse N. Digestive histopathological presentation of IPEX syndrome. Mod. Pathol. 2009, 22:95-102.
21. Lewis J.E., Fu S.M., Gaskin F. Autoimmunity, end organ damage and the origin of autoantibodies and autoreactive T cells in systemic lupus erythematosus. Discov. Med. 2013, 15:85-92.
22. Haskins K., Cooke A. CD4 T cells and their antigens in the pathogenesis of autoimmune diabetes. Curr. Opin. Immunol. 2011, 23:739-745.
23. Rottembourg D., Deal C., Lambert M., Mallone R., Carel J.-C., Lacroix A., et al. 21-Hydroxylase epitopes are targeted by CD8 T cells in autoimmune Addison's disease. J. Autoimmun. 2010, 35(23):309-315.
24. Mariño E., Grey S.T. B cells as effectors and regulators of autoimmunity. Autoimmunity 2012, 45:377-387.
25. Aschermann S., Lehmann C.H.K., Mihai S., Schett G., Dudziak D., Nimmerjahn F. B cells are critical for autoimmune pathology in Scurfy mice. Proc. Natl. Acad. Sci. 2013, 110:19042-19047.
26. Lim H.W., Hillsamer P., Banham A., Kim C.H. Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells. J. Immunol. 2005, 175:4180-4183.
27. Iikuni N., Lourenço E.V., Hahn B.H., La Cava A. Cutting edge: regulatory T cells directly suppress B cells in systemic lupus erythematosus. J. Immunol. 2009, 183:1518-1522.
28. + follicular regulatory T cells control the germinal center response. Nat. Med. 2011, 17:975-982.
29. Chung Y., Tanaka S., Chu F., Nurieva R.I., Martinez G.J., Rawal S., et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat. Med. 2011, 17:983-988.
30. Kinnunen T., Chamberlain N., Morbach H., Choi J., Kim S., Craft J., et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood 2013, 121:1595-1603.
31. Derbinski J., Gäbler J., Brors B., Tierling S., Jonnakuty S., Hergenhahn M., et al. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 2005, 202:33-34.
32. Kuroda N., Mitani T., Takeda N., Ishimaru N., Arakaki R., Hayashi Y., et al. Development of autoimmunity against transcriptionally unrepressed target antigen in the thymus of Aire-deficient mice. J. Immunol. 2005, 174:1862-1870.
33. Ramsey C., Winqvist O., Puhakka L., Halonen M., Moro A., Kämpe O., et al. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum. Mol. Genet. 2002, 11:397-409.
34. Niki S., Oshikawa K., Mouri Y., Hirota F., Matsushima A., Yano M., et al. Alteration of intra-pancreatic target-organ specificity by abrogation of Aire in NOD mice. J. Clin. Invest. 2006, 116:1292-1301.
35. Anderson M.S., Venanzi E.S., Chen Z., Berzins S.P., Benoist C., Mathis D. The cellular mechanism of Aire control of T cell tolerance. Immunity 2005, 23:227-239.
36. Aschenbrenner K., D'Cruz L.M., Vollmann E.H., Hinterberger M., Emmerich J., Swee L.K. Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+medullary thymic epithelial cells. Nat. Immunol. 2007, 8:351-358.